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Objective: To present some of our experience with BiobraneTM (a total of 703 patients
in 7 years) in a range of uses in burn practice and to illustrate the caveats that
we have found applicable in maintaining our success with this versatile material.
Methods: Retrospective analysis of theatre records, medical notes, and photography
database to categorize our experience with Biobrane. Thorough assessment of our surgi-
cal and nursing protocols (both literature and experience inﬂuenced) to identify caveats
for successful use. Results: Pivotal steps are revealed in wound selection, wound prepa-
ration, material application, dressing, and subsequent nursing care that have led to
overwhelming success in deﬁnitive management of superﬁcial partial thickness to mid-
dermal burns (ensuring pain relief, allowing early mobilization, tolerance of dressing
changes and therapy, and earlier hospital discharge). Its many uses in a broad range of
common burn situations are demonstrated and tips provided to achieve best outcome.
Conclusions: Biobrane is not a panacea but it is extremely versatile. The different
potential uses have learning curves, and suggestions are provided to ﬂatten these.
BiobraneTM was ﬁrst introduced for the treatment of burn wounds and donor sites in 1979.1
Itisabiosyntheticsemipermeablemembranedesignedtotemporarilyperformthefunctions
of lost epidermis until reepithelialization. It is bilaminate material (Fig 1), consisting of a
woven nonbiodegradable nylon mesh, the superﬁcial (outer) surface of which has a silastic
coating (a mechanical barrier to vapor loss and bacterial ingress). Peptides derived from
porcine type I collagen are bonded to all exposed nylon and silicone surfaces. The material
bonds ﬁrmly to the adequately prepared bed of an appropriate burn (superﬁcial partial
thickness to middermal injury) until spontaneous detachment by reepithelialization. It is
a lightweight material and is packaged and stored as dry sheets or gloves and has a long
shelf-life. Our experience with Biobrane (a total of 703 patients in 7 years) reveals many
other applications in burns practice, with some patients receiving Biobrane for more than
1 application.
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Figure 1. Cross-sectional electron micrograph of Biobrane structure.
USES OF BIOBRANE
“Standard” Biobrane (15/3 denier nylon ﬁbers) has been used exclusively for the following
applications. The number in parentheses represents the number of cases in which Biobrane
has been used for each application:
 Deﬁnitive treatment of superﬁcial partial thickness and mid-dermal burns (484 as sole
treatmentplus86wheregraftingwasperformedinanotherareaduringthesameoperation)
 “Trial of life” (retrospectively indistinguishable from graft reduction, see below)
 Graft Reduction (plus “trial of life”—65)
 Salvage in the elderly (30)
 Graft holding in difﬁcult sites (35)
 Graft holding in deep areas surrounded by superﬁcial burn (33)
 Postdermabrasion dressing (9)
 Retention of cell suspensions (65)
 Temporizing dressing postexcision of full-thickness burn (18)
Deﬁnitive treatment
Failure of Biobrane, when it is used for the deﬁnitive treatment of superﬁcial partial thick-
ness to middermal burns, is rare in my practice. Success, however, is governed by a number
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Figure 2. Deﬁnitive management of superﬁcial partial thickness burns with Biobrane. An exten-
sively blistered burn wound (a) is meticulously cleaned (b) a Biobrane glove has been applied (c)
excellent healing occurs by day 9 (d).
of caveats that I have found to be unbreakable. Loss of Biobrane is chieﬂy due to nonadher-
ence followed by infection. It cannot be used as deﬁnitive treatment in deeper (nonexuding)
burns; these require excision and split skin grafting. The primary caveat, therefore, is burn
selection. Obvious exudation, or the presence of blisters (popped or intact), indicates an in-
tact subdermal circulation (Fig 2a). An exuding wound bed often cannot be fully appraised
without the second caveat—meticulous wound cleaning and preparation (Fig 2b). This has
seldom been possible without general anesthesia since it involves aggressive cleaning to
remove blister roofs/fragments, other nonviable tissue, and surface contaminants such as
dirt and soot. This process also reduces surface contamination by organisms that might
have populated the wound during the “cooling” process (clean running water not always
available) or during the burning process (wound infection seems more common in burns
caused by “organic” agents such as cooking oils, stocks and water, sauces, petrol, etc).
Following cleaning,the burn wound and an area of surrounding unburned skin (up to 10 cm
from the burn edge) is shaved of hair. Hair might “lay down” during dressing application,
but springs up later—the dressing detaches, and air pockets develop, which encourage bac-
terial ingress. Burns involving hands or feet need nail trimming and scrubbing to reduce
these as a source of bacteria. These preparatory stages occur before “scrubbing up.” After
full surgical scrub, the skin is prepared with full-strength BetadineTM and sterile drapes
are applied around the surgical ﬁeld. Residual Betadine is washed off with saline—it can
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be an irritant under Biobrane, especially at the unburned margin. Tincture of Benzoin
applied around the burn helps both Biobrane and adhesive tapes to adhere. Biobrane is
applied (silastic shiny side out) and anchored at one margin with a 4-cm wide strip of
sterile HypaﬁxTM. The opposite side is then similarly anchored under slight tension to
eradicate any wrinkling of the Biobrane. The other 2 sides are then anchored; it is useful to
pick up the edge of the Biobrane with the tape that can then be pulled outward, affording
required tension and ensuring excellent apposition of Biobrane and burn. On the limbs,
Biobraneoverdressedwithfull-strengthBetadine-soakedNufoldgauzedriesout,becoming
stiff, uncomfortable, and resistant to movement/exercise. Weak (1 in 10) Betadine (100-mL
Betadine made up to 1 L with sterile 0.9% saline) remains soft and conforming. To reduce
dressing bulk, the gauze is held on directly with crˆ epe bandage, reducing heat and moisture
at the wound site and limiting maceration. On the trunk, Biobrane is overdressed with
ActicoatTM and Hypaﬁx—the treated back lies on an ExudryTM while the treated front
is covered by CutilinTM. Postoperatively the treated part is elevated. Outer dressings are
replaced daily. Certain structures, the nipples and the umbilicus in particular, should not
be covered with Biobrane. A hole is cut out of the Biobrane to allow these structures to
be externalized. Betadine ointment is applied to reduce their potential as bacterial sources.
The Biobrane glove has reduced surgical time after preparation for hand burns from 30–40
minutes each down to 5–10 minutes each (Fig 2c). The ﬁngers are wrapped individually,
the palm bolstered and a “boxing glove” created (with MCPJs, PIPs, and DIPS in ﬂexion)
with a crˆ epe bandage. This maximally stretches the dorsal hand burns in the knowledge
that it is easier to regain ﬁnger extension than ﬁnger ﬂexion (Fig 2d).
“Trial of Life”
Even after meticulous preparation, some burns appear to sit on the boundary between mid-
and deep dermal; sometimes the boundary itself is indistinct. These burns sluggishly reﬁll
and the exudation from them is minimal; but if they might be even slightly capable of
healing spontaneously, they receive Biobrane as a “Trial of Life.” Preparation of the burn
wound is exactly the same as for deﬁnitive treatment, but the patient is counseled that
success is not guaranteed and excision and grafting may be required if Biobrane fails over
the deeper areas.
Graft reduction
In certain circumstances, a heterogeneous burn with an equivocal edge to the deeper areas
receives Biobrane, according to deﬁnitive treatment protocols (Fig 3a). In these cases, there
is no doubt that these areas need to be excised and grafted but Biobrane is applied to
allow the more superﬁcial burns around them to heal and the edge to demarcate clearly. At
excision,onlynonviabletissueisexcisedandtheleastamountofgraftpossibleisnecessary
(Figs 3b and 3c).
Salvage in the elderly
Theprogressivethinningofthedermisandreductioninthedensityofadenexalstructuresin
theelderlydoesnot enableaccuratepredictionof spontaneoushealinginburns thatinitially
appear to be superﬁcial partial thickness/mid-dermal in depth. This fact often catches out
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Figure 3. Graft reduction; the superﬁcial burn components heal with Biobrane while the deeper
area demarcates allowing accurate grafting with minimal sacriﬁce of viable tissue.
primarycaregiverswhotreatwithsilversulfadiazine(SSD)creamorActicoatanddiscover,
at review a few days later, that the burn has deepened, necessitating excision and grafting.
Biobrane applied within 24 hours of the injury (and usually within a couple of hours of
immediate post–burn admission) can salvage these burns (Figs 4a and 4b). Whether due to
decontamination and preparation of the burn or the application of Biobrane, this procedure
is more frequently successful than not (Figs 4c and 4d). Since the elderly cope poorly
with a split-skin graft donor site (in terms of both healing and mobilization), this salvage
considerably reduces the morbidity of their injury. Failure is usually obvious within 3 days
and deﬁnitive excision and grafting can then be performed.
Autograft holding in difﬁcult sites
In major burn injury >50% total body surface area (TBSA), where the back is involved
and the patient initially managed on the intensive care unit (ICU), shear causes problems
with split skin grafts on the back (despite TherakairTM mattresses). Shear often results from
pulling the patient up the bed when being nursed at 30◦–45◦ to reduce facial swelling.
When Biobrane is applied over meshed split skin graft, it adheres ﬁrmly to the interstices;
effectively “spot-welding” it into place (Fig 7d). Acticoat and Exudry outer dressings are
applied, and Biobrane is examined daily. The graft is normally well taken by day 7 when
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Figure 4. Salvageintheelderly;initiallyappearingsuperﬁcial,thisburnina78-year-oldstruggled
to heal spontaneously but resulted in the best outcome.
SSD cream is applied (which loosens the ﬁbrous clots holding the Biobrane) and the
material can be removed easily on day 8. This process does not appear to delay healing of
the interstices at all. Biobrane also markedly assists in the holding of widely meshed skin
grafts over vascularized IntegraTM during the serial delamination/grafting cycle in major
burn injury.
Autograft holding in deep areas surrounded by superﬁcial burn
In cases of heterogeneous burns where the burn requiring excision is well demarcated
immediately (Fig 5a), the deeper areas are excised and grafted (Fig 5b). If these areas are
within a patch of superﬁcial burn, Biobrane is applied over the whole wound (Fig 5c). The
superﬁcial burn is thus deﬁnitively treated by the Biobrane and the graft is ﬁrmly held in
place. When the superﬁcial areas are clinically healed (usually by day 9 or 10), SSD cream
is applied as for “graft holding in difﬁcult sites.”
Postdermabrasion dressing
When dermabrasion has been used for burn scar contour correction or repigmentation of
burn hypopigmentation (Figs 6a and 6b), Biobrane is often an excellent dressing option,
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Figure 5. Once the deeper areas have been excised, Biobrane holds the graft and allows the
superﬁcial surrounds to heal spontaneously. Note that the nipple has been excluded from the
Biobrane and has been treated with Betadine ointment.
since the dermabraded bed is effectively a superﬁcial partial thickness/middermal wound.
This option is possible only if a hemostatic tumescent technique has been employed to
facilitate the surgery. In my experience, Biobrane applied to a bleeding bed is held by dense
blood clot rather than ﬁne ﬁbrous clot and its subsequent detachment and removal is much
more difﬁcult.
Retention of cell suspensions
When cultured keratinocyte suspensions are applied over meshed split skin graft in our
patients with burns >50% TBSA, Biobrane is the retention dressing of choice (Fig 7d).
Despitethe1-mmporespresentintheﬁlm,thesilasticlayergenerallyminimizescell/media
loss. This appears to be more effective than other commonly used materials such as
SurfasoftTM.
Temporizing dressing postburn excision
The tumescent technique we employ enables the complete excision of all burn eschar (even
in >80% TBSA burns; Fig 7a). Temporary closure is then essential until physiological
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Figure 6. Forehead dermabrasion receives Biobrane, which isalsoused toretainacell suspension.
improvementisdisplayedbythepatient.Availablesplit-skingraftorIntegraisneverapplied
within the ﬁrst 48 hours of burn excision in the patient in the ICU. Any physiological
deterioration in this time tends to result in the use of inotropes, which shut down the
peripheral circulation. This can result in loss of graft and Integra and conversion of skin
graftdonorsitestofull-thicknessinjuries(notonlyincreasingthesizeofthewoundneeding
grafting but reducing donor site availability). Following burn excision, therefore, Biobrane
is applied to the underlying fat as a temporizing dressing (Figs 7b and 7c). This usually
stays in situ for 3 to 6 days until deﬁnitive closure can be afforded (most often with Integra
although the back is always grafted).
DISCUSSION
Tojustifyitsexpenseandoperativeplacementundergeneralanesthesia,theuseofBiobrane
for the deﬁnitive management of spontaneously healing burns has to display advantages
over alternative, less invasive dressing regimes. The 2 main parameters are the degree of
postoperative pain and the length of stay in hospital. A third parameter might be the time
to return to work. Pain is extremely important; it dictates how much narcotic analgesic will
be required. This, together with the need for physiotherapy and occupational therapy, will
dictate how quickly and how completely the patient will regain function. Obviously, the
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Figure 7. An 80% TBSA burn (a) receives Biobrane initially as a temporizing dressing (b and c)
and later to hold meshed graft and cultured cell suspension (d) resulting in healing (e).
sooner patients can cope with their injury by themselves, the sooner they can be discharged
and the sooner they will return to work.
In2007,wesurveyed60patients,withanaverageageof42.4years(range,16–82),who
had received Biobrane for deﬁnitive treatment of superﬁcial partial thickness to middermal
burns. We were interested in their pain scores, measured by Visual Analogue Scale, before
andaftertheapplicationofBiobrane.Overall,thebackgroundpainscorebeforeapplication
was 6.4, rising with examination. Most also remembered feeling “groggy” due to opiates.
After the application of Biobrane, the pain scores fell to an average of 3.8. This fall in pain
score is despite 8 patients of the 60 surveyed who complained that pain increased after the
Biobrane application (presumably due to the aggression of their in-theatre debridement).
The average time to return to work was 4.5 weeks, longest in those with hand burns and
working in hot environments (foundries, kitchens, etc). Figures from the Burns Round-
Table (comparative data for all Burns Services in Australia and New Zealand) show that we
enjoy the shortest lengths of stay of any unit. The appropriate use of Biobrane in superﬁcial
partial thickness and middermal burns has been pivotal in enabling earlier discharge. Our
general experience with Biobrane use tallies well with the experience of its early evaluators
in several applications.
Retrospectiveanalysisalsoshows thatBiobranebecomesprogressivelymore effective
in reducing length of stay as the burn size increases (Table 1).
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Table 1. Hospital stay with increasing burn size after Biobrane application
Burn range 1%–4% 5%–9% 10%–19% 20%–29% 30%–39%
(sample number) (n = 334) (n = 72) (n = 42) (n = 13) (n = 8)
Average TBSA 2.52 7.13 12.43 22.54 33.63
Length of stay 4.73 8.07 9.69 11.85 13.13
Days/TBSA 1.88 1.13 0.78 0.53 0.39
A small number of patients skewed the data, spending far longer in hospital than their
group peers. Further analysis of demography and burn site revealed that patients stayed in
hospital longer if they
– were elderly,
– lived alone or were homeless,
– came from rural locations, and
– hadhandburnsrequiringtherapyorburnstoother“specialareas”(feet,genitalia,breasts,
buttocks) making early discharge impossible.
Those patients from 2002 (my ﬁrst year as a burns specialist) stayed slightly longer than
subsequent years; an obvious learning curve. Readers might question such aggressive
management of small (<10% TBSA) burns by this method and why this particular course
is favored. I am the sole burns surgeon in a State unit with 8 beds and 20 nurses and
responsiblefor a catchmentarea of 2.4 millionsquare kilometers.In 2008, we accepted456
admissions and the unit managed more than 2500 outpatient visits. Without the expeditious
applicationof Biobrane,thisworkload could notbe managedwithoutgreatlyincreasingthe
in-andoutpatientdressingburdenonthenursesandincreasingthelengthofstay.Additional
support for this aggressive approach is provided by Phillips et al.2 Their paper reported
experience on 851 patients and identiﬁed 2 potential areas of Biobrane failure; namely
inaccurate assessment of burn depth and application of Biobrane over pretreated wounds.
Removal of all nonviable tissue and meticulous cleaning of the burn bed to stimulate
exudation eradicates both these concerns. The infection rate (5.8%) reported in that paper
is 10-fold greater than our own.
The need for meticulous preparation of superﬁcial burns before the application of
Biobrane is not a new concept. Demling3 elucidated most of the factors I ﬁnd important,
althoughhemakesnoreferencetowhetherhis“aggressivedebridement”requiredageneral
anesthetic. He also highlights that Biobrane will not adhere in deeper wound environments,
using the failure of Biobrane in such cases as a diagnostic test similar to my “trial of life”
application.
I have been asked on several occasions why I apply Biobrane rather than cadaver
allograft as a temporizing dressing after excision of major burn injury. The 2 cadaver banks
available to Adelaide are based in Melbourne (Victoria, Australia) and Auckland (New
Zealand). Both have faced great difﬁculty in generating and maintaining stock, and more
often than not, requests for large volumes of allograft are not met with supply, because
of stock shortage or exhaustion. Cadaver allograft from both sources is expensive and of
variable quality. It has a limited shelf life and the Therapeutics Goods Administration will
not allow its storage in Adelaide if it is not used immediately. Stock that has displayed
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“acceptable” contamination with Staphylococcus aureus or other potential pathogens is
sometimes provided. Distance (Melbourne to Adelaide, 732 km; Auckland to Adelaide,
3750 km) and delay (both banks are at least 1 airplane ﬂight away) compound the supply
problem. Many of these issues were raised by Purdue and colleagues4 during their prospec-
tive study in 1985–1987. This multicenter study failed to show any signiﬁcant difference
between cadaver allograft and Biobrane for this application while awaiting deﬁnitive auto-
grafting.
Even the use of Biobrane to hold meshed autograft has historical precedent with
previousauthorshavingsimilarsuccesswhencomparingBiobranewitharangeofbiological
materials including cadaver allograft and porcine xenograft.1,5
The success of early authors (particularly J. F. Hansbrough6 and W. Hansbrough7)
in making Biobrane work on donor sites has been impossible to emulate. I thought that
fastidious donor site preparation with adrenaline tumescence (so that the donor site does
not bleed but merely exudes serum) would guarantee success. However, Biobrane seemed
consistently to become “cemented” to the donor site with sanguinous clot. Its detachment
wasalmostimpossiblewithoutanestheticandremovaldisturbedreepithelialization.Patients
also complained that they found its presence on donor sites to be extremely uncomfortable
and outer dressing changes excruciating. In addition, the quality of reepithelialization
appearsmorefragileduringreharvestingthanmyusualhydrocolloidmethod.Theseﬁndings
were considerably disappointing since success would certainly have been advantageous
in major burn injury (reducing dressing time, allowing continuation of the temporizing
Biobrane sheets over adjacent donor areas, retaining cultured keratinocyte suspensions
for expedition of donor site reepithelialization, etc). Since I have had great success with
hydrocolloids in donor site management, Biobrane was discontinued for this application.
Similarly, the use of Biobrane on the face is difﬁcult and disappointing. The elasticity
that confers excellent appositional advantage on convex surfaces such as the limbs and
trunk causes the material to “tent” over concavities such as the orbits, nasomaxillary, and
nasolabial folds. The need to staple or suture the material into these creases removed
any advantage over soft parafﬁn face care. We enjoyed great success with TranscyteTM in
face management, especially in the intensive care setting, ﬁnding face care to be its only
indication;agreeingwithDemlingandDeSanti.8 RemovalofTranscytefromthemarkethas
prompted a return to simple parafﬁn face care, although we occasionally use AquacelAgTM
in intubated patients.
The adherence of Biobrane is probably due to the conversion of ﬁbrinogen (in the burn
exudate) to monomeric ﬁbrin following its exposure to Biobrane’s “foreign” fragments of
porcine collagen. The material is then held by the ﬁne, ﬁbrous “clot.” This explains its
failure to adhere to deeper (nonexuding) burn wounds. The same process occurs when
Biobrane is applied to a bleeding wound bed, except the result is a dense blood clot that
makesdetachmentproblematic.Theﬁbrovascularingrowth,whichoccurswhenBiobraneis
appliedtoexcisedburnbedsfollowingdeepburndebridement,canbedisastrousifignored.
Thenylonscaffoldisnotbiodegradableand,onceingrown,requiressurgicalremoval(often
setting the wound back). Although I have several indications for applying Biobrane to a
deep wound bed (graft holding and temporization of the burn wound in the big burn), strict
protocols ensure its timely and easy removal in these situations.9
Problems with Biobrane are more frequently a fault of technique rather than material.
Biobrane is quite ubiquitous when one remembers what it consists of and realizes what can
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be expected of it.10 Like all burn treatments, it is not a panacea; it is a tool that has speciﬁc
uses. It has disadvantages also. In Australia, it has only very recently been granted the
Therapeutic Goods Administration approval for use, previously restricting those who could
use it, requiring annual submission of cases in whom it had been used, plus a letter from
the hospital ethics committee supporting its continued use. It is expensive relative to other
dressing materials for spontaneously healing burns (especially the gloves). The meticulous
woundpreparationnecessaryforsuccessrequiresageneralanesthetic,orBiobranelosscan
be expected. Regulation has made it a highly specialised dressing, so discharge of patients
treated with Biobrane to rural areas is usually delayed. It cannot be applied on delayed
presentation burns. Considerable experience is necessary for use in other roles (ie, graft
holding) but experience has been difﬁcult to acquire previously because of regulation.
Standard nursing management
A robust nursing protocol must exist to monitor the progression of the product and direct
nursing intervention, especially when Biobrane is introduced as a new product into a burns
service or used on outlying patients from the burns unit (eg, ICU). Biobrane gloves are
encased in a “boxing glove” bandage and left intact for 3 days. Biobrane applied for
any indication except dermabrasion (where the risk of surface contamination is minimal)
is inspected daily for signs of infection or nonadherence. Any air or ﬂuid collections
are removed. If Acticoat is used as the outer dressing, this is lifted, Biobrane inspected,
and Acticoat placed back in position, only being replaced as per normal use. Once exudate
ceases,adrydressingcanbeapplied.Oneofthemainchallengesistopreventtheinadvertent
early removal of Biobrane before it has been allowed to fulﬁll its function. If Hypaﬁx or
staples are used to ﬁx the material, they should not be removed prior to the product being
well adhered. Trimming of Biobrane occurs as the material becomes dry and opaque,
indicating healed burn underneath.
If Biobrane does not adhere, but there is a clean wound underneath, the nurses are
instructed not to remove the product. In the case of a localized nonadherent area associated
with purulence, only the local area should be deroofed. Swabs from the underlying wound
should be taken and sent for microbial culture, the wound cleaned and Acticoat applied. In
the case of widespread nonadherence associated with purulence, an urgent medical review
is sought. Normal practice in this situation is removal of all loose Biobrane, wound swabs
are taken for culture, the wound is cleaned, and Acticoat is applied.
CONCLUSION
Biobrane is ubiquitous and used in my practice for a range of applications. It is relatively
inexpensive, easy to store, apply and ﬁx, and reliable when used according to guidelines.
In the deﬁnitive management of burns expected to heal spontaneously, failure is very
uncommon. Although experience is necessary for the other applications mentioned, use is
usually rewarded with a course and result at least comparable with, and usually better than,
any alternative (Fig 7e). It is important, however, to know its limitations. Recently, Aubrey
Woodroof (the inventor of Biobrane) has developed an Advanced Wound Bioengineered
Alternative Tissue (AWBATTM).11 This material employs a similar structure to Biobrane
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except the nylon ﬁlaments are ﬁner (15/2 denier on standard AWBAT), the pores are more
regular and frequent with uninterrupted nylon mesh ﬂooring them and the porcine collagen
peptides are not cross-linked (providing less steric hindrance in their interaction with burn
wound exudate), thus expediting adherence. I look forward to comparing this new material
with Biobrane.
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